Serum-compatible aptamer-regulated RCA–CRISPR/Cas12a assay for fluorescence and lateral flow detection of myeloperoxidase
Microchimica Acta · 2026
DOI: 10.1007/s00604-026-08427-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2026. Verfasst von Yingying Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fuzhou University Affiliated Provincial Hospital, Fuzhou University, Fuzhou, 350002, P. R. China. Hauptthemen laut MEDLINE: Peroxidase, Aptamers, Nucleotide, Biosensing Techniques, CRISPR-Cas Systems. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Fujian Medical University Qihang funds, the National Filing Science and Technology Project.
Abstract (Originalsprache)
Myeloperoxidase (MPO), a neutrophil-derived heme peroxidase involved in oxidative inflammatory responses, has been investigated as a biomarker for cardiovascular, hematological, and other inflammation-associated diseases. In this study, an aptamer-regulated rolling circle amplification (RCA)-CRISPR/Cas12a fluorescence assay was established for MPO detection in serum samples. Two aptamers, Apt-02 and Apt-14, were obtained with dissociation constants (KD) of 57.76 and 56.88 nM, respectively, using MPO-depleted human serum as the counter-selection matrix during MB-SELEX. Apt-14 exhibited relatively good stability in serum and was therefore used in the assay development. Upon MPO binding, cDNA was released from the aptamer/cDNA duplex, initiating RCA and subsequently activating Cas12a-mediated trans-cleavage to amplify the fluorescence signal. Under the optimized conditions, the assay achieved a detection limit of 0.422 ng/mL with good selectivity. It also showed limited interference from the tested cardiovascular disease-related proteins and provided MPO levels in clinical serum samples that were consistent with ELISA results. The assay was also adapted to a lateral-flow strip using a biotin/FAM-labeled ssDNA reporter, enabling visual detection and reader-assisted semi-quantitative analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fuzhou University Affiliated Provincial Hospital, Fuzhou University, Fuzhou, 350002, P. R. China.
- Fujian Key Laboratory of Aptamers Technology, Fuzong Clinical Medical College of Fujian Medical University (900th Hospital), Fuzhou, 350025, P. R. China.
- Zhongxiang People's Hospital, Zhongxiang, 431900, P. R. China.
- Fuzhou University Affiliated Provincial Hospital, Fuzhou University, Fuzhou, 350002, P. R. China. Huangyi@fjsl.com.cn.
- Fujian Key Laboratory of Aptamers Technology, Fuzong Clinical Medical College of Fujian Medical University (900th Hospital), Fuzhou, 350025, P. R. China. fzzyyzsh@126.com.
Förderung
- Fujian Medical University Qihang funds
- the National Filing Science and Technology Project
Zitieren
APA
Cao, Y., Duan, M., Wei, L., Chen, Y., Liu, F., Bai, J., Huang, Y., & Zhang, S. (2026). Serum-compatible aptamer-regulated RCA–CRISPR/Cas12a assay for fluorescence and lateral flow detection of myeloperoxidase. Microchimica Acta. https://doi.org/10.1007/s00604-026-08427-3
Vancouver
Cao Y, Duan M, Wei L, Chen Y, Liu F, Bai J, et al. Serum-compatible aptamer-regulated RCA–CRISPR/Cas12a assay for fluorescence and lateral flow detection of myeloperoxidase. Microchimica Acta. 2026. doi:10.1007/s00604-026-08427-3
BibTeX
@article{Cao2026,
author = {Cao, Yingying and Duan, Mengchen and Wei, Lizhen and Chen, Yisheng and Liu, Fei and Bai, Jiawen and Huang, Yi and Zhang, Shenghang},
title = {Serum-compatible aptamer-regulated RCA–CRISPR/Cas12a assay for fluorescence and lateral flow detection of myeloperoxidase},
journal = {Microchimica Acta},
year = {2026},
doi = {10.1007/s00604-026-08427-3}
}
EUVIMED